Patents by Inventor Pei-Ling Hsu

Pei-Ling Hsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210015401
    Abstract: A respiratory function testing system includes an air transforming device, a sound reception device and an operation device. The air transforming device is configured to collect exhaled and/or inhaled air for a predetermined period and generate a wide frequency range sound signal according to the collected respired air. The wide frequency range sound signal at least contains an ultrasonic signal. The sound reception device is configured to receive and record the wide frequency range sound signal as an audio file. The operation device is in communication with the sound reception device and is configured to receive and compute the audio file to generate a respiratory function parameter. Besides, the recorded wide frequency range sound signal may be converted into a spectrogram for further applications, and the computation of the audio file can be replaced by analyzing the spectrogram. A respiratory function testing method corresponding to the respiratory function testing system is also provided.
    Type: Application
    Filed: October 5, 2020
    Publication date: January 21, 2021
    Inventors: Chia-Chi SU, Hsiao-Pao YEN, Pei-Ling HSU, Chia-Hung CHEN
  • Publication number: 20170042503
    Abstract: A respiratory function testing system includes an air transforming device, a sound reception device and an operation device. The air transforming device is configured to collect exhaled air for a predetermined period and generate a full-range sound signal according to the collected exhaled air. The full-range sound signal at least contains an ultrasonic signal. The sound reception device is configured to receive and record the full-range sound signal. The operation device is in communication with the sound reception device and is configured to receive and compute the ultrasonic signal contained in the full-range sound signal recorded by the sound reception device to generate a respiratory function parameter. A respiratory function testing method of the respiratory function testing system is also provided.
    Type: Application
    Filed: August 10, 2016
    Publication date: February 16, 2017
    Inventors: CHIA-CHI SU, HSIAO-PAO YEN, PEI-LING HSU, CHIA-HUNG CHEN
  • Publication number: 20140281991
    Abstract: A user interface is displayed in a handheld device, and is used to control an electronic device electrically connected to the handheld device. The user interface includes at least one function selection region, an execution region, and a display region. The execution region is surrounded by the function selection region, and is electrically connected to the function selection region. The execution region is used to execute a function of the function selection region, and is used to send a comment corresponding to the execution region to the electronic device. When the function selection region is selected, the display region displays first information corresponding to the function selection region. When the execution region is pressed, the display region displays second information fed back from the electronic device to the handheld device in accordance with the comment.
    Type: Application
    Filed: March 18, 2013
    Publication date: September 18, 2014
    Applicant: AVERMEDIA TECHNOLOGIES, INC.
    Inventors: Chia-Chen CHAO, Shou-Kuo TAI, Wen-Chi YEN, Pei-Ling HSU, Ya-Ling HSU, Chun-Tang HSU
  • Patent number: 8557579
    Abstract: Compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The compounds and methods of the invention can be used to control unwanted T cell- or NK cell-mediated immune responses in conditions such as autoimmune diseases, transplant rejection, and allergic diseases.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: October 15, 2013
    Assignee: AbGenomics Cooperatief U.A.
    Inventors: Rong-Hwa Lin, Chung-Hsiun Wu, Pei-Ling Hsu
  • Publication number: 20130011861
    Abstract: Compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The compounds and methods of the invention can be used to control unwanted T cell- or NK cell-mediated immune responses in conditions such as autoimmune diseases, transplant rejection, and allergic diseases.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicant: AbGenomics Cooperatief U.A..
    Inventors: Rong-Hwa Lin, Chung-Hsiun Wu, Pei-Ling Hsu
  • Patent number: 8298540
    Abstract: Compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The compounds and methods of the invention can be used to control unwanted T cell- or NK cell-mediated immune responses in conditions such as autoimmune diseases, transplant rejection, and allergic diseases.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: October 30, 2012
    Assignee: AbGenomics Cooperatief U.A.
    Inventors: Rong-Hwa Lin, Chung-Hsiun Wu, Pei-Ling Hsu
  • Patent number: 7744888
    Abstract: Compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The compounds and methods of the invention can be used to control unwanted T cell- or NK cell-mediated immune responses in conditions such as autoimmune diseases, transplant rejection, and allergic diseases.
    Type: Grant
    Filed: January 18, 2002
    Date of Patent: June 29, 2010
    Assignee: AbGenomics Cooperatief U.A.
    Inventors: Rong-Hwa Lin, Chung-Hsiun Wu, Pei-Ling Hsu
  • Publication number: 20090304709
    Abstract: Compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The compounds and methods of the invention can be used to control unwanted T cell- or NK cell-mediated immune responses in conditions such as autoimmune diseases, transplant rejection, and allergic diseases.
    Type: Application
    Filed: June 29, 2009
    Publication date: December 10, 2009
    Applicant: AbGenomics Coöperatief U.A.
    Inventors: RONG-HWA LIN, CHUNG-HSIUN WU, PEI-LING HSU
  • Patent number: 6838654
    Abstract: A first device comprising a first current mirror is used to amplify the output of a first photodetector. A second device comprising a current mirror arrangement is employed to amplify the output of a second photodetector. The outputs of the two devices are then compared to provide a signal useful for many applications, including that for determining the position of a rotating member or of a member in relative motion to another member. Preferably, no feedback action is used for the amplification of the output of at least one of the photodetectors.
    Type: Grant
    Filed: January 17, 2002
    Date of Patent: January 4, 2005
    Assignee: Capella Microsystems, Inc.
    Inventors: Brian N. Kuo, Ing-Jye Lan, Koon Wing Tsang, Pei-Ling Hsu
  • Patent number: 6800462
    Abstract: The invention is directed to methods of producing a protein by administering a nucleic acid encoding the protein to an animal. Following the administration of the nucleic acid to the animal, the protein is produced in vivo and is isolated by removing a biological sample from the animal. These methods allow for the rapid and efficient production and isolation of a protein encoded by any nucleic acid sequence of interest and can be used to generate antibodies that bind to the protein sequence.
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: October 5, 2004
    Assignee: AbGenomics Corporation
    Inventors: Chung-Hsiun Wu, Rong-Hwa Lin, Pei-Ling Hsu
  • Publication number: 20030189164
    Abstract: A first device comprising a first current mirror is used to amplify the output of a first photodetector. A second device comprising a current mirror arrangement is employed to amplify the output of a second photodetector. The outputs of the two devices are then compared to provide a signal useful for many applications, including that for determining the position of a rotating member or of a member in relative motion to another member. Preferably, no feedback action is used for the amplification of the output of at least one of the photodetectors.
    Type: Application
    Filed: January 17, 2002
    Publication date: October 9, 2003
    Applicant: CAPELLA MICROSYSTEMS, INC.
    Inventors: Brian N. Kuo, Ing-Jye Lan, Koon Wing Tsang, Pei-Ling Hsu
  • Publication number: 20030049801
    Abstract: The invention is directed to methods of producing a protein by administering a nucleic acid encoding the protein to an animal. Following the administration of the nucleic acid to the animal, the protein is produced in vivo and is isolated by removing a biological sample from the animal. These methods allow for the rapid and efficient production and isolation of a protein encoded by any nucleic acid sequence of interest and can be used to generate antibodies that bind to the protein sequence.
    Type: Application
    Filed: February 14, 2002
    Publication date: March 13, 2003
    Inventors: Chung-Hsiun Wu, Rong-Hwa Lin, Pei-Ling Hsu
  • Publication number: 20030049252
    Abstract: Compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The compounds and methods of the invention can be used to control unwanted T cell- or NK cell-mediated immune responses in conditions such as autoimmune diseases, transplant rejection, and allergic diseases.
    Type: Application
    Filed: January 18, 2002
    Publication date: March 13, 2003
    Inventors: Rong-Hwa Lin, Chung-Hsiun Wu, Pei-Ling Hsu
  • Publication number: 20030049694
    Abstract: The invention is directed to methods of producing a fusion protein by administering a nucleic acid encoding the fusion protein to an animal. Following the administration of the nucleic acid to the animal, the protein is produced in vivo and is isolated by removing a biological sample from the animal. These methods allow for the rapid and efficient production and isolation of a protein encoded by any nucleic acid sequence of interest. A fusion protein purified according to these methods can be used to screen for target binding molecules, such as antibodies, that bind to a protein sequence of interest.
    Type: Application
    Filed: February 14, 2002
    Publication date: March 13, 2003
    Inventors: Chung-Hsiun Wu, Rong-Hwa Lin, Pei-Ling Hsu